Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 27

1.

Differences in the receptor status between primary and recurrent breast cancer--the frequency of and the reasons for discordance.

Heitz F, Barinoff J, du Bois O, Hils R, Fisseler-Eckhoff A, Harter P, Heitz J, Willenbrock K, Traut A, du Bois A.

Oncology. 2013;84(6):319-25. doi: 10.1159/000346184. Epub 2013 Apr 19.

PMID:
23615456
2.

Interobserver agreement of proliferation index (Ki-67) outperforms mitotic count in pulmonary carcinoids.

Warth A, Fink L, Fisseler-Eckhoff A, Jonigk D, Keller M, Ott G, Rieker RJ, Sinn P, Söder S, Soltermann A, Willenbrock K, Weichert W; Pulmonary Pathology Working Group of the German Society of Pathology.

Virchows Arch. 2013 May;462(5):507-13. doi: 10.1007/s00428-013-1408-2. Epub 2013 Apr 5.

PMID:
23559305
3.

[Tumor infiltrates suspicious of carcinoma in mediastinal lymph nodes].

Willenbrock K, Fisseler-Eckhoff A.

Pathologe. 2012 Nov;33(6):560-2. doi: 10.1007/s00292-012-1695-4. German.

PMID:
23052351
4.

[A rare cause of recurrent small bowel intussusception. Case report and review of the literature].

Haist T, Behrens A, Willenbrock K, Fisseler-Eckhoff A, Ell C, Lorenz D.

Chirurg. 2012 Jun;83(6):568-71. doi: 10.1007/s00104-012-2313-y. Review. German.

PMID:
22695813
5.

Gene expression profiling of isolated tumour cells from anaplastic large cell lymphomas: insights into its cellular origin, pathogenesis and relation to Hodgkin lymphoma.

Eckerle S, Brune V, Döring C, Tiacci E, Bohle V, Sundström C, Kodet R, Paulli M, Falini B, Klapper W, Chaubert AB, Willenbrock K, Metzler D, Bräuninger A, Küppers R, Hansmann ML.

Leukemia. 2009 Nov;23(11):2129-38. doi: 10.1038/leu.2009.161. Epub 2009 Aug 6.

PMID:
19657361
6.

The expression of activation induced cytidine deaminase in follicular lymphoma is independent of prognosis and stage.

Willenbrock K, Renné C, Rottenkolber M, Klapper W, Dreyling M, Engelhard M, Küppers R, Hansmann ML, Jungnickel B.

Histopathology. 2009 Mar;54(4):509-12. doi: 10.1111/j.1365-2559.2009.03241.x. No abstract available.

PMID:
19309412
7.

Expression of activation-induced cytidine deaminase in malignant lymphomas infiltrating the bone marrow.

Engels K, Jungnickel B, Tobollik S, Hansmann ML, Kriener S, Willenbrock K.

Appl Immunohistochem Mol Morphol. 2008 Dec;16(6):521-9. doi: 10.1097/PAI.0b013e3181758ce5.

PMID:
18776814
8.

[Global gene expression analysis and novel signalling pathways in Hodgkin lymphoma].

Bräuninger A, Renné C, Willenbrock K, Martin-Subero JI, Hinsch N, Tiacci E, Siebert R, Küppers R, Hansmann ML.

Verh Dtsch Ges Pathol. 2006;90:136-41. German.

PMID:
17867590
9.

Frequent occurrence of B-cell lymphomas in angioimmunoblastic T-cell lymphoma and proliferation of Epstein-Barr virus-infected cells in early cases.

Willenbrock K, Bräuninger A, Hansmann ML.

Br J Haematol. 2007 Sep;138(6):733-9. Epub 2007 Aug 2.

PMID:
17672882
10.

Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6.

Mottok A, Renné C, Willenbrock K, Hansmann ML, Bräuninger A.

Blood. 2007 Nov 1;110(9):3387-90. Epub 2007 Jul 25.

11.

High expression of several tyrosine kinases and activation of the PI3K/AKT pathway in mediastinal large B cell lymphoma reveals further similarities to Hodgkin lymphoma.

Renné C, Willenbrock K, Martin-Subero JI, Hinsch N, Döring C, Tiacci E, Klapper W, Möller P, Küppers R, Hansmann ML, Siebert R, Bräuninger A.

Leukemia. 2007 Apr;21(4):780-7.

PMID:
17375124
12.

The aberrant coexpression of several receptor tyrosine kinases is largely restricted to EBV-negative cases of classical Hodgkin's lymphoma.

Renné C, Hinsch N, Willenbrock K, Fuchs M, Klapper W, Engert A, Küppers R, Hansmann ML, Bräuninger A.

Int J Cancer. 2007 Jun 1;120(11):2504-9.

13.

[Villous adenoma of the renal pelvis and ureter].

Frickmann H, Jungblut S, Bargon J, Willenbrock K, Störkel S, Hanke P.

Urologe A. 2006 Nov;45(11):1435-7. German.

PMID:
16900367
14.

[Pathology of Hodgkin's lymphoma].

Hansmann ML, Willenbrock K.

Verh Dtsch Ges Pathol. 2003;87:53-7. German.

PMID:
16888894
15.

Common features and differences in the transcriptome of large cell anaplastic lymphoma and classical Hodgkin's lymphoma.

Willenbrock K, Küppers R, Renné C, Brune V, Eckerle S, Weidmann E, Bräuninger A, Hansmann ML.

Haematologica. 2006 May;91(5):596-604.

16.
17.

Human splenic marginal zone B cells lack expression of activation-induced cytidine deaminase.

Willenbrock K, Jungnickel B, Hansmann ML, Küppers R.

Eur J Immunol. 2005 Oct;35(10):3002-7.

18.

Autocrine- and paracrine-activated receptor tyrosine kinases in classic Hodgkin lymphoma.

Renné C, Willenbrock K, Küppers R, Hansmann ML, Bräuninger A.

Blood. 2005 May 15;105(10):4051-9. Epub 2005 Jan 27.

19.

In angioimmunoblastic T-cell lymphoma, neoplastic T cells may be a minor cell population. A molecular single-cell and immunohistochemical study.

Willenbrock K, Renné C, Gaulard P, Hansmann ML.

Virchows Arch. 2005 Jan;446(1):15-20. Epub 2004 Oct 5.

PMID:
15480765
20.

[Early detection of colorectal tumors: CT or MRI?].

Luboldt W, Hoepffner N, Holzer K, Jacobi V, Willenbrock K, Woeste G, Bechstein WO, Vogl TJ.

Radiologe. 2003 Feb;43(2):136-50. German.

PMID:
12624671
21.

T-cell variant of classical Hodgkin's lymphoma with nodal and cutaneous manifestations demonstrated by single-cell polymerase chain reaction.

Willenbrock K, Ichinohasama R, Kadin ME, Miura I, Terui T, Meguro K, Fukuhara O, DeCoteau JF, Hansmann ML.

Lab Invest. 2002 Sep;82(9):1103-9.

PMID:
12218070
22.

[WHO classification of Hodgkin's lymphoma and its molecular pathological relevance].

Hansmann ML, Willenbrock K.

Pathologe. 2002 May;23(3):207-18. Review. German.

PMID:
12089788
23.

Cytogenetic and molecular characterization of a patient with simultaneous B-cell chronic lymphocytic leukemia and peripheral T-cell lymphoma.

Martin-Subero JI, Siebert R, Harder L, Gesk S, Schwindt P, Bräuninger A, Willenbrock K, Steinemann D, Tiemann M, Calasanz MJ, Grote W, Ludwig WD, Hansmann ML, Schlegelberger B.

Am J Hematol. 2001 Dec;68(4):276-9.

24.

Survival and clonal expansion of mutating "forbidden" (immunoglobulin receptor-deficient) epstein-barr virus-infected b cells in angioimmunoblastic t cell lymphoma.

Bräuninger A, Spieker T, Willenbrock K, Gaulard P, Wacker HH, Rajewsky K, Hansmann ML, Küppers R.

J Exp Med. 2001 Oct 1;194(7):927-40.

26.
27.

Supplemental Content

Loading ...
Support Center